Article
Peptides vs. Proteins: Where the Line Falls and Why It Matters
Both are chains of amino acids. The difference is length, and the cutoff depends on who is counting.
In this article
Key takeaways
Peptides and proteins are both chains of amino acids; the difference is length. There is no agreed scientific cutoff, but FDA counts any chain longer than 40 amino acids as a protein, which is why insulin (51) is regulated as a biological product.
- Evidence available
- Regulatory documents
- Confidence
- High The definitions come from the federal regulation, the rule that introduced it, and two NIH references; delivery figures come from an FDA label and published reviews.
- Main limitation
- The scientific boundary between peptide and protein is a convention, and other sources draw it at different lengths than FDA does.

U.S. regulatory status
- Semaglutide tabletsRybelsus® (Novo Nordisk)
FDA-approved for this use
As an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes
Source 9, verified
- Semaglutide tabletsRybelsus® (Novo Nordisk)
FDA-approved for this use
To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events
Source 9, verified
- Semaglutide tabletsOzempic® tablets (Novo Nordisk)
FDA-approved for this use
As an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes
Source 9, verified
- Semaglutide tabletsOzempic® tablets (Novo Nordisk)
FDA-approved for this use
To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events
Source 9, verified
Peptides and proteins are built the same way: amino acids joined end to end by peptide bonds. What separates them is length, and scientists have never agreed on an exact cutoff. The vocabulary that indexes PubMed describes proteins as larger versions of peptides that can fold into complex structures such as enzymes and receptors 5. FDA, which needs a firm rule, counts any chain of more than 40 amino acids as a protein 6.
That line sounds like a technicality. It decides which set of laws a medicine is regulated under, and it is why insulin, the first commercial peptide drug, is a protein in FDA’s eyes.
Where the line between a peptide and a protein falls
Different references draw the line in different places. NIH’s genetics glossary describes a peptide as a short chain of typically 2 to 50 amino acids, calls a chain of 51 or more a polypeptide, and says the proteins made inside cells are built from one or more polypeptides 12. The National Library of Medicine’s Medical Subject Headings (MeSH), the vocabulary used to index PubMed, splits the range differently: chains of about 2 to 12 amino acids are oligopeptides, and chains of about 13 or more are polypeptides 5. A protein is a polypeptide whose sequence of amino acids determines the shape it folds into, and that shape determines what the protein does 11.
When FDA wrote its own definition in 2020, it said plainly that there are no precise, agreed-upon definitions of “protein,” “polypeptide” and “peptide.” It also found that sources agree on the basics: all three are chains of alpha amino acids linked by peptide bonds 7.
Why FDA draws the line at 40
FDA’s definition is in federal regulations: a protein is any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size. When two or more chains are associated with each other the way they are in nature, their amino acids are counted together 6. The rule took effect on March 23, 2020, at the end of a 10-year transition period set by federal law (the BPCI Act of 2009) 7.
The number matters because “protein” is one of the categories of biological product in the same regulation 6. A marketing application for a biological product goes through the Public Health Service Act, not the drug provisions of the Food, Drug, and Cosmetic Act 7. A chain of 40 amino acids or fewer is not a protein under this definition 6.
Is insulin a peptide or a protein?
It depends on who is counting. Insulin is two chains, one of 21 amino acids and one of 30, linked by disulfide bonds 8. A 2022 review of therapeutic peptides calls it the first commercial peptide drug, from 1923 2. FDA adds the two chains together, gets 51, and concludes that insulin is a protein 7, which places it on the biological-product side of the line.
Why most peptide medicines are injected
The gut is built to take proteins apart, and it does the same to peptide drugs. Enzymes break them down before they can be absorbed, and the intestinal lining lets little of what remains through. A 2013 review put the oral bioavailability of proteins typically below 1 to 2 percent 1. For that reason most peptide and protein medicines are given by routes other than the mouth, mainly injection 3.
A short life in the blood is a second problem. Natural GLP-1, a 30-amino-acid hormone made in the gut, has a half-life of about 1.5 minutes after intravenous administration in humans 10. Drug developers lengthen that by swapping amino acids at the sites where enzymes cut, or by attaching a fatty acid that makes the peptide bind to albumin in the blood 2,10. Semaglutide was designed using albumin binding 10.
What it takes to make a peptide work as a pill
Oral peptide medicines exist, and they show how hard the problem is. Semaglutide tablets are made with an absorption enhancer called SNAC, and most of the absorption happens in the stomach 9. Even so, FDA’s label estimates absolute bioavailability at about 0.4 to 1 percent for Rybelsus® (Novo Nordisk) and about 1 to 2 percent for Ozempic® tablets (Novo Nordisk) 9. In other words, almost all of each tablet’s semaglutide never reaches the bloodstream.
Both tablets are FDA-approved, as an adjunct to diet and exercise, to improve blood sugar control in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for them 9.
Researchers are testing other ways around the gut, including enzyme inhibitors, absorption enhancers, chemical modification and nanoparticle carriers 3. Reviews of this work are cautious. The 2013 review concluded that no major breakthrough in effective oral delivery of polypeptides and proteins had yet been achieved 1.
How many peptide medicines are there?
More than 80 peptide drugs have been approved worldwide, according to the 2022 review 2. New ones arrive a few at a time: of the 50 novel drugs FDA approved in 2024, two were peptides 4.
What size alone cannot tell you
Knowing that a molecule is a peptide tells you how it is built. It does not tell you whether it works or whether it is safe for a particular use. Those answers come from studies in people, and for a medicine, from whether FDA approved that specific product for that use. That is why our pages give approval status product by product, with the document it comes from.
Sources
12 sources. Numbers in the text link to the entry they cite.
- 1.
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla J, Vadlapudi AD, Patel A, et al. Int J Pharm. 2013.
Review PMID 23428883 DOI 10.1016/j.ijpharm.2013.02.030Checked October 18, 2026
Cited for: Proteins typically have oral bioavailability below 1 to 2 percent; barriers are enzymatic degradation and poor intestinal penetration; no major breakthrough in oral delivery of polypeptides and proteins (as of 2013)
- 2.
Therapeutic peptides: current applications and future directions
Wang L, Wang N, Zhang W, et al. Signal Transduct Target Ther. 2022.
Review PMID 35165272 DOI 10.1038/s41392-022-00904-4Checked October 18, 2026
Cited for: Insulin described as the first commercial peptide drug (1923); more than 80 peptide drugs approved worldwide; half-life extension by non-natural amino acids at cleavage sites and by fatty-acid conjugation
- 3.
Recent Progress in the Oral Delivery of Therapeutic Peptides and Proteins: Overview of Pharmaceutical Strategies to Overcome Absorption Hurdles
Mehrotra S, Kalyan Bg P, Nayak PG, et al. Adv Pharm Bull. 2024.
Review PMID 38585454 DOI 10.34172/apb.2024.009Checked October 18, 2026
Cited for: Peptide and protein formulations are mostly delivered parenterally; strategies under study include absorption enhancers, enzyme inhibition, chemical modification and particulate carriers
- 4.
2024 FDA TIDES (Peptides and Oligonucleotides) Harvest
Al Musaimi O, AlShaer D, de la Torre BG, Albericio F. Pharmaceuticals (Basel). 2025.
Review PMID 40143070 DOI 10.3390/ph18030291Checked October 18, 2026
Cited for: FDA approved 50 novel drugs in 2024, two of them peptides
- 5.
Peptides (MeSH descriptor D010455)
National Library of Medicine. Medical Subject Headings (MeSH).
Other sourcemeshb.nlm.nih.govChecked October 18, 2026
Cited for: Oligopeptides about 2 to 12 amino acids, polypeptides about 13 or more; proteins described as larger versions of peptides that can form complex structures such as enzymes and receptors
- 6.
21 CFR 600.3 Definitions, paragraph (h)(6) (protein)
U.S. Food and Drug Administration. Electronic Code of Federal Regulations. 2026.
Regulatory documentecfr.govChecked October 18, 2026
Cited for: A protein is an alpha amino acid polymer with a specific, defined sequence of more than 40 amino acids; naturally associated chains counted together; protein is a category of biological product (600.3(h))
Back to text (a)Back to text (b)Back to text (c)Back to text (d)
- 7.
Definition of the Term “Biological Product” (final rule, 85 FR 10057, document 2020-03505)
U.S. Food and Drug Administration. Federal Register. 2020.
Regulatory documentfederalregister.govChecked October 18, 2026
Cited for: No precise, agreed-upon definitions of protein, polypeptide and peptide; all are chains of alpha amino acids linked by peptide bonds; effective March 23, 2020, end of the BPCI Act 10-year transition; biological product applications go under section 351 of the PHS Act; insulin counted as 51 amino acids and therefore a protein
Back to text (a)Back to text (b)Back to text (c)Back to text (d)
- 8.
Insulin (MeSH descriptor D007328)
National Library of Medicine. Medical Subject Headings (MeSH).
Other sourcemeshb.nlm.nih.govChecked October 18, 2026
Cited for: Insulin has an A chain of 21 residues and a B chain of 30, linked by two disulfide bonds (51 amino acids)
- 9.
RYBELSUS (semaglutide) tablets, for oral use; OZEMPIC (semaglutide) tablets, for oral use: prescribing information (effective 2026-01-30)
Novo Nordisk. DailyMed. 2026.
Product labeldailymed.nlm.nih.govChecked October 18, 2026
Cited for: Tablets co-formulated with SNAC; absorption mainly in the stomach; estimated absolute bioavailability about 0.4% to 1% (Rybelsus®) and 1% to 2% (Ozempic® tablets); indications in section 1
- 10.
The Discovery and Development of Liraglutide and Semaglutide
Knudsen LB, Lau J. Front Endocrinol (Lausanne). 2019.
Review PMID 31031702 DOI 10.3389/fendo.2019.00155Checked October 18, 2026
Cited for: GLP-1 is a 30-amino-acid hormone with a half-life of 1.5 minutes after intravenous dosing in humans; reversible albumin binding used to extend the action of liraglutide and semaglutide
- 11.
Proteins (MeSH descriptor D011506)
National Library of Medicine. Medical Subject Headings (MeSH).
Other sourcemeshb.nlm.nih.govChecked October 18, 2026
Cited for: The amino acid sequence of a protein determines the shape it folds into and its function
- 12.
Peptide (Talking Glossary of Genomic and Genetic Terms)
National Human Genome Research Institute (NIH). NHGRI Talking Glossary. 2026.
Other sourcegenome.govChecked October 18, 2026
Cited for: A peptide is a short chain of amino acids (typically 2 to 50); a chain of 51 or more is a polypeptide; proteins made inside cells are made from one or more polypeptides
